Bone Dose Constraints for 4-Fraction SBRT
For 4-fraction SBRT to bone metastases, the spinal cord maximum point dose (Dmax) should not exceed 23.0 Gy to maintain radiation myelopathy risk at 1-5%, while vertebral compression fracture risk ranges from 10-20% and is primarily influenced by total dose and fractionation schedule. 1
Spinal Cord Constraints
The most critical constraint for spine SBRT is spinal cord tolerance. For 4-fraction regimens specifically, the thecal sac/spinal cord Dmax should be limited to 23.0 Gy to keep the risk of radiation myelopathy between 1-5%. 1 This represents the most rigorous modeling of spinal cord tolerance data available for SBRT.
Key Spinal Cord Principles:
- Pre-SBRT MRI is strongly recommended to precisely delineate the spinal cord 2
- The frequency of radiation-induced myelopathy following spine SBRT remains low at <2% when constraints are respected 2
- For reirradiation scenarios, additional factors become critical: cumulative thecal sac EQD2₂ Dmax should remain ≤70 Gy, with SBRT contribution ≤25 Gy EQD2₂ 1
Vertebral Body and Fracture Risk
Vertebral compression fracture (VCF) is the most clinically relevant toxicity after SBRT, occurring in 10-20% of cases. 2 This risk is directly influenced by prescribed dose and fractionation:
- Single-fraction SBRT doses >20 Gy carry greater fracture risk compared to fractionated regimens 2
- Fractionated SBRT (including 4-fraction schedules) has not been associated with higher VCF risk compared to conventional RT 2
- Most VCFs rarely require invasive management 2
Critical Pre-Treatment Assessment:
If the Spinal Instability Neoplastic Score (SINS) exceeds 7, stabilizing intervention should be performed before RT to reduce secondary fracture risk. 2 This is a mandatory evaluation step that directly impacts morbidity.
Non-Spine Bone Constraints
For non-spine bone metastases treated with SBRT, the main complications are:
- Rib fractures: 2.5%
- Femur fractures: 1.9% 2
The evidence shows that 4-fraction regimens for non-spine sites typically use doses ranging from 24-50 Gy in 3-5 fractions, with local control around 90% and low toxicity rates. 3
Additional Toxicity Considerations
Acute pain flare occurs in up to 30% of patients after SBRT, similar to conventional 3D radiotherapy. 2 This is a common but self-limited toxicity that should be anticipated and managed with prophylactic dexamethasone.
Concurrent Systemic Therapy Warning:
Particular attention is required when SBRT is performed with concurrent systemic treatment due to potential radiosensitizing effects that may increase toxicity risk. 2
Practical 4-Fraction Dosing Context
While the question asks specifically about 4-fraction constraints, the recent ESTRO guidelines recommend high-dose SBRT regimens including schedules such as 1×20 Gy, 1×24 Gy, 2×12 Gy, 3×10 Gy, and 5×7 Gy. 2 The 4-fraction schedule is less commonly reported in the literature compared to 1,3, or 5-fraction regimens, but the spinal cord constraint of 23.0 Gy Dmax remains the definitive limit. 1
The key algorithmic approach:
- Assess spinal stability (SINS score) - if >7, surgical stabilization first
- Obtain pre-treatment MRI for cord delineation
- Limit spinal cord Dmax to 23.0 Gy for 4 fractions
- Accept 10-20% VCF risk, which is rarely clinically significant
- Consider prophylactic steroids for pain flare
- Adjust for concurrent systemic therapy radiosensitization